Literature DB >> 7399323

Are serum bile salt concentrations raised in hyperlipidaemia?

G J Beckett, J G Douglas, N D Finlayson, I W Percy-Robb.   

Abstract

We have studied serum fasting and postprandial primary bile salt concentrations in a group of 10 consecutive hyperlipidaemic subjects. The efficiency of hepatic bile salt clearance in the same subjects was aslo studied using an injected dose of sodium glycocholate. No increase in serum fasting or postprandial concentrations of the primary bile salts were observed and hepatic bile salt clearance was only marginally abnormal in one subject. The presence of hyperlipidaemia does not invalidate the use of serum conjugated bile salt analysis for the detection of liver diseases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7399323      PMCID: PMC1420344          DOI: 10.1136/gut.21.3.219

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Validity and sensitivity of an intravenous bile acid tolerance test in patients with liver disease.

Authors:  N F LaRusso; N E Hoffman; A F Hofmann; M G Korman
Journal:  N Engl J Med       Date:  1975-06-05       Impact factor: 91.245

2.  Effect of age on liver function with particular reference to bromsulphalein excretion.

Authors:  E N Thompson; R Williams
Journal:  Gut       Date:  1965-06       Impact factor: 23.059

3.  Investigations into the choice of immunogen, ligand, antiserum and assay conditions for the radioimmunoassay of conjugated cholic acid.

Authors:  G J Beckett; W M Hunter; I W Percy-Robb
Journal:  Clin Chim Acta       Date:  1978-09-01       Impact factor: 3.786

4.  Serum-bile-acids in the stagnant-loop syndrome.

Authors:  B Lewis; S Tabaqchali; D Panveliwalla; I D Wootton
Journal:  Lancet       Date:  1969-02-01       Impact factor: 79.321

5.  Postprandial serum bile acid for the detection of hepatobiliary disease.

Authors:  N Kaplowitz; E Kok; N B Javitt
Journal:  JAMA       Date:  1973-07-16       Impact factor: 56.272

6.  Serum bile acids in the diagnosis of hepatobiliary disease.

Authors:  C R Pennington; P E Ross; I A Bouchier
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

7.  Serum bile acids in patients with hyperlipidaemia.

Authors:  C R Pennington; P E Ross; M C Bateson; I A Bouchier
Journal:  J Clin Pathol       Date:  1978-01       Impact factor: 3.411

8.  The effect of age on the intravenous sodium glycocholate test.

Authors:  G J Beckett; J G Douglas; I A Nimmo; N D Finlayson; I W Percy-Robb
Journal:  Clin Chim Acta       Date:  1980-01-31       Impact factor: 3.786

9.  The preparation of 125I-labelled bile acid ligands for use in the radioimmunoassay of bile acids.

Authors:  G J Beckett; J E Corrie; I W Percy-Robb
Journal:  Clin Chim Acta       Date:  1979-04-02       Impact factor: 3.786

  9 in total
  2 in total

1.  Clinical value of bile salt tests in anicteric liver disease.

Authors:  J G Douglas; G J Beckett; I A Nimmo; N D Finlayson; I W Percy-Robb
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

2.  Lysinuric protein intolerance mutation is expressed in the plasma membrane of cultured skin fibroblasts.

Authors:  D W Smith; C R Scriver; H S Tenenhouse; O Simell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.